Allergan names current Catalent CFO as its CFO

Allergan PLC named Matthew Walsh its chief financial officer, when he formally joins the company “later this month.” Walsh is currently the CFO of Catalent Inc. . Walsh will succeed Allergan’s current CFO Tessa Hilado, who said in September that she would retire when a replacement was found. Allergan’s stock, which slipped 0.3% in premarket trade, has slipped 1.4% over the past three months through Friday, while the S&P 500 has gained 6.7%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply